Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro
- PMID: 8647946
- PMCID: PMC507339
- DOI: 10.1172/JCI118701
Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro
Abstract
Dietary phosphorus (P) restriction is known to ameliorate secondary hyperparathyroidism in renal failure patients. In early renal failure, this effect may be mediated by an increase in 1,25-(OH)2D3, whereas in advanced renal failure, P restriction can act independent of changes in 1,25-(OH)2D3 and serum ionized calcium (ICa). In this study, we examined the effects of dietary P on serum PTH, PTH mRNA, and parathyroid gland (PTG) hyperplasia in uremic rats. Normal and uremic rats were maintained on a low (0.2%) or high (0.8%) P diet for 2 mo. PTG weight and serum PTH were similar in both groups of normal rats and in uremic rats fed the 0.2% P diet. In contrast, there were significant increases in serum PTH (130 +/- 25 vs. 35 +/- 3.5 pg/ml, P < 0.01), PTG weight (1.80 +/- 0.13 vs. 0.88 +/- 0.06 microg/gram of body weight, P < 0.01), and PTG DNA (1.63 +/- 0.24 vs. 0.94 +/- 0.07 microg DNA/gland, P < 0.01) in the uremic rats fed the 0.8% P diet as compared with uremic rats fed the 0.2% P diet. Serum ICa and 1,25-(OH)2D3 were not altered over this range of dietary P, suggesting a direct effect of P on PTG function. We tested this possibility in organ cultures of rat PTGs. While PTH secretion was acutely (30 min) regulated by medium calcium, the effects of medium P were not evident until 3 h. During a 6-h incubation, PTH accumulation was significantly greater in the 2.8 mM P medium than in the 0.2 mM P medium (1,706 +/- 215 vs. 1,033 +/- 209 pg/microg DNA, P < 0.02); the medium ICa was 1.25 mM in both conditions. Medium P did not alter PTH mRNA in this system, but cycloheximide (10 microg/ml) abolished the effect of P on PTH secretion. Thus, the effect of P is posttranscriptional, affecting PTH at a translational or posttranslational step. Collectively, these in vivo and in vitro results demonstrate a direct action of P on PTG function that is independent of ICa and 1,25-(OH)2D3.
Similar articles
-
A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content.Am J Kidney Dis. 1997 Jul;30(1):105-12. doi: 10.1016/s0272-6386(97)90571-0. Am J Kidney Dis. 1997. PMID: 9214408
-
In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.Endocrinology. 1997 Jun;138(6):2596-600. doi: 10.1210/endo.138.6.5181. Endocrinology. 1997. PMID: 9165053
-
Hyperplasia of the parathyroid gland without secondary hyperparathyroidism.Kidney Int. 2002 Apr;61(4):1332-8. doi: 10.1046/j.1523-1755.2002.00265.x. Kidney Int. 2002. PMID: 11918740
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Role of phosphorus in the pathogenesis of secondary hyperparathyroidism.Am J Kidney Dis. 2001 Jan;37(1 Suppl 2):S54-7. doi: 10.1053/ajkd.2001.20740. Am J Kidney Dis. 2001. PMID: 11158862 Review.
Cited by
-
Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease.Int J Mol Sci. 2020 Jun 18;21(12):4332. doi: 10.3390/ijms21124332. Int J Mol Sci. 2020. PMID: 32570711 Free PMC article. Review.
-
Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention.NDT Plus. 2008 Aug;1(Suppl 3):iii2-iii8. doi: 10.1093/ndtplus/sfn079. NDT Plus. 2008. PMID: 25983967 Free PMC article.
-
Regulation of parathyroid function in chronic kidney disease (CKD).Clin Exp Nephrol. 2006 Sep;10(3):175-9. doi: 10.1007/s10157-006-0432-9. Clin Exp Nephrol. 2006. PMID: 17009074 Review.
-
Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial.Clin J Am Soc Nephrol. 2009 Jan;4(1):178-85. doi: 10.2215/CJN.02830608. Epub 2008 Dec 3. Clin J Am Soc Nephrol. 2009. PMID: 19056618 Free PMC article. Clinical Trial.
-
Soymilk intake has desirable effects on phosphorus and calcium metabolism.J Clin Biochem Nutr. 2018 May;62(3):259-263. doi: 10.3164/jcbn.17-79. Epub 2018 Feb 17. J Clin Biochem Nutr. 2018. PMID: 29892166 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous